Advanced solid tumor Trials in Jinan, China
Conditions / Advanced solid tumor / Jinan, China
Advanced solid tumor has been the subject of sustained clinical investigation across multiple research sites.
38 total trials for this combination
Showing top 10 of 38 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06233942 | Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors | RECRUITING | — |
| NCT06625593 | A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors | RECRUITING | — |
| NCT06607185 | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04237805 | A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients | RECRUITING | PHASE1/PHASE2 |
| NCT05875168 | First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT05780307 | IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1 |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT04215978 | Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT06859762 | A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT05420545 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | UNKNOWN | PHASE1 |